Dianthus Therapeutics, Inc. is headquartered in New York City. The company is focused on developing complement therapeutics for patients with severe autoimmune and inflammatory diseases.

Inc. (“Dianthus”), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, today announced ...

Live webcasts of the Company’s presentations may be accessed under “News and Events” in the Investors section of the Dianthus Therapeutics website.

Jan. 08, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics ... of antibody complement therapeutics to treat severe autoimmune diseases, today announced the company’s participation at the 43rd ...

Dianthus Therapeutics is a clinical-stage biotechnology ... for people living with severe autoimmune and inflammatory diseases. To learn more, please visit www.dianthustx.com and follow us on ...